Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Long Term Provisions

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Long Term Provisions History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Long Term Provisions ₹173 Cr₹172 Cr₹157 Cr₹75 Cr₹47 Cr

What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?

The latest Long Term Provisions ratio of AUROBINDO PHARMA is ₹173 Cr based on Mar2023 Consolidated results.
Year Long Term Provisions
Mar2023₹173 Cr
Mar2022₹172 Cr
Mar2021₹157 Cr
Mar2020₹75 Cr
Mar2019₹47 Cr

How is Long Term Provisions of AUROBINDO PHARMA Trending?

Years Long Term Provisions % Change
Mar2023 ₹173 Cr
0.54
Mar2022 ₹172 Cr
9.34
Mar2021 ₹157 Cr
110.29
Mar2020 ₹75 Cr
60.53
Mar2019 ₹47 Cr -

Compare Long Term Provisions of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,536.7 Cr 1.9% 3.6% 87.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.9%

3.6%

87.2%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses